Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

The University of British Columbia

$24,872.00

Single-cell omics approaches for anticancer camptothecin biosynthetic pathway elucidation

FY 2023-24

Summary
Many plant metabolites are potent anticancer drugs or promising drug candidates to be developed further. For example, topotecan and irinotecan, derivatives of the natural product camptothecin (CPT), are highly relevant anticancer compounds with a market of more than 1 billion dollars1. Despite these immense values, their clinical potential is not fully realized because of their low natural abundance in a few slow-growing and/or endangered plant species. Therefore, elucidation of plant metabolic pathways has enormous potential for us to tap into the treasure trove of novel chemistries across the Plant Kingdom. Major hurdles in progress on the elucidation of the CPT biosynthetic pathway include: (1) genes in this pathway are not co-regulated or co-localized in the genome, and (2) biosynthetic pathways are localized not only to distinct organs, such as bark and leaves but also to distinct cell types within these organs. Therefore, the advent of single-cell omics technologies has enormous potential to revolutionize metabolic pathway gene discovery. The goals of this research collaboration between the Dang (University of British Columbia Okanagan, UBC) and Buell (University of Georgia Atlanta, UGA) groups are to (1) Obtain high-quality single-cell transcriptomics of camptothecin-producing plants; (2) Utilize the obtained omics data set to mine and identify genes involved in the complex biosynthetic pathway leading to the anticancer compound camptothecin. By leveraging Dr. Buell's group expertise in single-cell genomics, my group, with expertise in medicinal plant pathway elucidation and metabolic engineering, is poised to accelerate and further develop Canada's leadership position in the omics and pharmaceutical industry. We anticipate excellent research and outstanding training opportunities from this collaboration.
Program
Alliance Grants
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
579871-2022
Name nom
Dang, Thu Thuy T
Department département
Okanagan - Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
24872
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5004
Research subject group en
Genetics
Research subject group fr
Genome analysis
Research subject en
Génétique
Research subject fr
Analyse du génome
Application title
Single-cell omics approaches for anticancer camptothecin biosynthetic pathway elucidation
Keyword
alkaloids; anticancer; enzymes; metabolic engineering; metabolomics; RNAseq; single-cell; transcriptomics
Application summary
Many plant metabolites are potent anticancer drugs or promising drug candidates to be developed further. For example, topotecan and irinotecan, derivatives of the natural product camptothecin (CPT), are highly relevant anticancer compounds with a market of more than 1 billion dollars1. Despite these immense values, their clinical potential is not fully realized because of their low natural abundance in a few slow-growing and/or endangered plant species. Therefore, elucidation of plant metabolic pathways has enormous potential for us to tap into the treasure trove of novel chemistries across the Plant Kingdom. Major hurdles in progress on the elucidation of the CPT biosynthetic pathway include: (1) genes in this pathway are not co-regulated or co-localized in the genome, and (2) biosynthetic pathways are localized not only to distinct organs, such as bark and leaves but also to distinct cell types within these organs. Therefore, the advent of single-cell omics technologies has enormous potential to revolutionize metabolic pathway gene discovery. The goals of this research collaboration between the Dang (University of British Columbia Okanagan, UBC) and Buell (University of Georgia Atlanta, UGA) groups are to (1) Obtain high-quality single-cell transcriptomics of camptothecin-producing plants; (2) Utilize the obtained omics data set to mine and identify genes involved in the complex biosynthetic pathway leading to the anticancer compound camptothecin. By leveraging Dr. Buell's group expertise in single-cell genomics, my group, with expertise in medicinal plant pathway elucidation and metabolic engineering, is poised to accelerate and further develop Canada's leadership position in the omics and pharmaceutical industry. We anticipate excellent research and outstanding training opportunities from this collaboration.
The University of British Columbia - $24,872 Grant (2… | Canada Spends